Pooled Results of Two Randomized Phase 3 Trials Evaluating VP-102
Channel: Research Square
Date: 19/02/2021

Eichenfield et al. "Pooled Results of Two Randomized Phase 3 Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum." Clinical Dermatology (2021). doi: 10.1007/s40257-020-00570-8

Read the article: https:// /doi.org/10.1007/s40257-020-00570-8
 
Video produced by http://researchsquare.com/researchers/videos